Resum
High-dose chemotherapy with autologous bone marrow or peripheral stem cell support is frequently used for the treatment of high-risk pediatric solid tumors. The gained experience with these treatments runs parallel with a considerable decrease on the procedure- related complications. These strategies have demonstrated its efectivity in the treatment of high-risk neuroblastoma as well as in refractory or relapsed germ cell tumors. There are also evidences showing that its use in high-risk Ewing's sarcoma, and in chemosensitive relapsed or metastatatic brain tumors, contributes to ameliorate the dismal prognosis of these patients.
| Títol traduït de la contribució | Intensive chemotherapy with stem cell support in non-hematological pediatric solid tumors: State of the art |
|---|---|
| Idioma original | Espanyol |
| Pàgines (de-a) | 5-10 |
| Nombre de pàgines | 6 |
| Revista | Clinical and Translational Oncology |
| Volum | 3 |
| Número | 1 |
| Estat de la publicació | Publicada - de gen. 2001 |
SDG de les Nacions Unides
Aquest resultat contribueix als següents objectius de desenvolupament sostenible.
